Are you a clinician, researcher or early-stage innovator with an idea that could create impact, change lives or improve health systems, but unsure how to take it beyond the lab?

Join ACMD and CHICC on Thursday 19 March for an engaging session on translating research concepts and health innovations into tangible outcomes for patients and healthcare systems.

Bringing together leaders from clinical research, translation, commercialisation and entrepreneurship, this event will explore why translating and commercialising matters and how it underpins the real-world impact of meaningful discoveries.

Through expert insights and practical case studies, speakers will share key considerations and lessons learned from their own commercialisation journeys, including:

• Why addressing unmet clinical and health system needs is the starting point for innovation
• How translation enables change, improving patient outcomes, optimising health services and supporting workforce experience
• The importance of health equity, improving access and affordability for diverse and underserved populations
• The mindset required for successful commercialisation, from purpose-driven design to global scalability
• What works (and what doesn’t) when moving from idea to impact.

Attendees will gain a clearer understanding of the pathway from research and early-stage innovation to real-world application, recognising that commercialisation isn’t all about business objectives or financial returns, but a purpose-driven pursuit to ensure breakthroughs reach the people and systems they were designed to help.

You’ll leave with practical takeaways, a fresh perspective and renewed inspiration to progress your own innovation journey.

EVENT DETAILS

Date: Thursday 19 March 2026

Time (AEDT): 9:00am – 11:00am

Venue: The Aikenhead Centre for Medical Discovery (ACMD), Auditorium, Level 1, 27 Victoria Parade, Fitzroy, VIC 3065

Speakers:

Andrew Batty, Chief Commercialisation Officer, ACMD

George Kenley, Head of Commercialisation Services, ANDHealth

Prof James Fallon, Chief Technical Officer, Bionics Institute | Head of Department, Medical Bionics Department, University of Melbourne

A/Prof Fiona Brownfoot, Co-Founder, Kali Healthcare | Clinician Scientist, The University of Melbourne | Obstetrician, The Mercy Hospital for Women

Dr Kyle Berean, Co-Founder and Head of Clinical Affairs, Atmo Biosciences

Dr Anabela Correia, Director, Inner Maven

Registration: Free to attend, but registration is essential.

Who should attend:

• Clinicians, researchers and scientists
• Early-stage innovators, founders and CXOs
• Medtech, digital and connected health professionals and service providers.